Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Black tea extract is a concentrated preparation derived from the fermented leaves of the Camellia sinensis plant, commonly used as a dietary supplement or ingredient in functional foods. Its primary constituents include polyphenols (notably theaflavins and thearubigins), caffeine, tannins, catechins, gallic acid, and various other secondary metabolites[2][5][8]. Black tea extract is purported to have antioxidant, anti-inflammatory, and potential cardioprotective effects, with research indicating possible roles in reducing the risk of cardiovascular disease, obesity, hyperlipidemia, diabetes, and certain cancers[2][8]. The mechanism of action is chiefly attributed to the polyphenolic content, which modulates oxidative stress, influences metabolic pathways, and may alter drug-metabolizing enzyme activity[8][10]. The extract is primarily used as a dietary supplement and functional food ingredient rather than a regulated pharmaceutical agent. Quality, ingredient composition, and potency can vary across commercial products, and regulatory oversight is limited compared to pharmaceuticals[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on black tea extract.